Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 34Genitourinary 2Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1Breast 1

Conditions

Sarcoma 2Mesothelioma, Malignant 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Tertiary Lymphoid Structures 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1MSI-H Colorectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Anus Neoplasms 1Advanced Refractory Solid Tumors 1

Interventions

Nivolumab 5Ipilimumab 3pembrolizumab 2durvalumab 2budigalimab 2venetoclax 1tislelizumab 1spartalizumab 1sargramostim 1rovalpituzumab tesirine 1regorafenib 1obinutuzumab 1naptumomab estafenatox 1epacadostat 1entinostat 1cemiplimab 1avelumab 1atezolizumab 1Thiotepa 1Tamoxifen 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Mesna 1Melphalan 1Immunotherapy, Adoptive 1Immune Checkpoint Inhibitors 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × regorafenib × Other solid neoplasm × Clear all
NCT03475953 2023-03-03

REGOMUNE

Institut Bergonié

Phase 1/2 Unknown
747 enrolled
BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡